Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Rosiglitazone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1231481C details an improved process for antidiabetic intermediates, replacing expensive Pd/C with Raney Nickel to achieve significant cost reduction in API manufacturing.
Patent CN1875018A reveals a safer, non-ether solvent reduction method for thiazolidinedione APIs, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.